Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
COVID-19 papain-like proteinase (PL-PRO) |
Target Info
|
Inhibitor |
[2] |
| MERS-CoV papain-like proteinase (PL-PRO) |
Target Info
|
Inhibitor |
[3] |
| SARS-CoV papain-like proteinase (PL-PRO) |
Target Info
|
Inhibitor |
[3] |
| References |
Top |
| REF 1 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| REF 2 |
Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020 Apr 9.
|
| REF 3 |
Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020 Mar;19(3):149-150.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
